NewsBenzingaNovo就Denecimig生物制品许可申请在美国的进展提供更新；FDA已告知Novo，Denecimig用于治疗A型血友病的BLA审评仍在进行中；FDA尚未就该BLA的监管行动给出新的时间表 Novo就Denecimig生物制品许可申请在美国的进展提供更新；FDA已告知Novo，Denecimig用于治疗A型血友病的BLA审评仍在进行中；FDA尚未就该BLA的监管行动给出新的时间表 Benzinga 2026.10.02 21:12 (GMT+0) Open on Benzinga Other news If You Invested $100 In Oracle Stock 20 Years Ago, You Would Have This Much Today Nike vs. Starbucks: One Beaten-Down Icon Is Primed for an Explosive Rebound Dividend Champion, Contender, And Challenger Highlights: Week October 4 If You Invested $100 In Flowserve Stock 5 Years Ago, You Would Have This Much Today Applied Digital: From Sell To Hold Ahead Of A High-Stakes Quarter (NASDAQ:APLD) Nvidia: Competition Caps The Upside Case (NASDAQ:NVDA)
